1990
DOI: 10.1164/ajrccm/142.1.91
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Cells and Eosinophilic Activity in Asthmatics Investigated by Bronchoalveolar Lavage: The Effects of Antiasthmatic Treatment with Budesonide or Terbutaline

Abstract: We investigated the constituents of bronchoalveolar lavage (BAL) regarding cell profiles and released eosinophilic cationic protein (ECP) in 11 patients treated occasionally with inhaled bronchodilators (Group A) and 11 patients treated regularly with inhaled corticosteroids (Group B). A normal, healthy control group of 12 subjects was also recruited. Compared with Group A, Group B had a reduced recovery percentage of infused volume (p less than 0.05) and total cell number (p less than 0.01). Compared with the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

17
119
4
5

Year Published

1996
1996
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 288 publications
(145 citation statements)
references
References 9 publications
17
119
4
5
Order By: Relevance
“…The concentrations we observed seemed slightly higher than those recorded by VIRCHOW et al [4], who examined concentrations of ECP in sputum of hospitalized asthmatics by rocking selected portions of spontaneous sputum with saline (mean±SEM, 878±1058 µg·L -1 ECP·g -1 sputum). The ECP concentrations in samples reported here were higher than those reported in bronchoalveolar lavage (BAL) in asthma [27,28], and in sputum mixed with saliva in healthy [5] or asthmatic subjects [5,29,30]. In BAL in asthmatics, ÄDELROTH et al [27] recorded values ranging 6.2±51 µg·L -1 .…”
Section: Discussioncontrasting
confidence: 49%
See 1 more Smart Citation
“…The concentrations we observed seemed slightly higher than those recorded by VIRCHOW et al [4], who examined concentrations of ECP in sputum of hospitalized asthmatics by rocking selected portions of spontaneous sputum with saline (mean±SEM, 878±1058 µg·L -1 ECP·g -1 sputum). The ECP concentrations in samples reported here were higher than those reported in bronchoalveolar lavage (BAL) in asthma [27,28], and in sputum mixed with saliva in healthy [5] or asthmatic subjects [5,29,30]. In BAL in asthmatics, ÄDELROTH et al [27] recorded values ranging 6.2±51 µg·L -1 .…”
Section: Discussioncontrasting
confidence: 49%
“…The ECP concentrations in samples reported here were higher than those reported in bronchoalveolar lavage (BAL) in asthma [27,28], and in sputum mixed with saliva in healthy [5] or asthmatic subjects [5,29,30]. In BAL in asthmatics, ÄDELROTH et al [27] recorded values ranging 6.2±51 µg·L -1 . BOUSQUET et al [28] did not detect ECP in 10 healthy subjects or 14 out of 38 asthmatics.…”
Section: Discussioncontrasting
confidence: 49%
“…Previous studies on links between eosinophils, eosinophil-derived proteins, and severity of disease have reported conflicting results such as the following: 1 ) a positive correlation between BAL ECP levels and clinical scores (16); 2) an inverse correlation between eosinophil numbers in BAL and airway responsiveness to MCh (20) and between MBP levels and airway reactivity to MCh (37); 3) no correlation between airway responsiveness to histamine and eosinophil or ECP levels (38). In addition, also in the present study, BAL epithelial cell number correlated with eosinophil number but not with ECP levels, while log Pd,, correlated with ECP levels, but not with BAL eosinophil number.…”
Section: Discussionmentioning
confidence: 99%
“…Differential cell counts in induced sputum were determined, and albumin and fibrinogen were measured as possible markers of capillary leakage [9], the chemokine interleukin-8 (IL-8) as a chemoattractant for neutrophils and primed eosinophils [11] and eosinophil cationic protein (ECP) as a toxic eosinophilic degranulation product [9,12]. Because the production and content of sputum might be influenced by disease severity and/or the presence of anti-inflammatory treatment, two groups of subjects were studied separately: one group of patients with mild asthma, treated only with short-acting β 2 -agonists on demand; and another group of patients with moderate-to-severe asthma, all receiving regular inhaled corticosteroid therapy.…”
mentioning
confidence: 99%